Photo Credit : WAM
Burjeel Holdings reported revenue of AED2.794 billion for the first half of 2026, representing a 4.4 percent increase compared with the same period last year.
The healthcare group’s EBITDA, excluding one-off items, increased by 24.6 percent year-on-year to AED517 million. Adjusted net profit nearly doubled, rising 97.4 percent to AED227 million.
Burjeel Holdings recorded more than 3.7 million patient visits during the six-month period, an increase of 9.9 percent from a year earlier. Patient visits grew by 12.4 percent during the second quarter, supported by higher demand for specialised services and a recovery in elective and high-acuity procedures.
Normalised revenue, excluding the impact of the Unified Procurement Programme, increased by 9.1 percent in the first half and 8.6 percent during the second quarter.
Inpatient revenue rose by 11.9 percent in the second quarter, while inpatient volumes increased by 7.2 percent during the first half. The group completed 24,610 surgeries during the second quarter, up 7.4 percent year-on-year.
The Hospitals segment generated AED2.501 billion in revenue, an increase of 5.4 percent, and accounted for 89 percent of the group’s total revenue.
The segment’s EBITDA, excluding one-off items, increased by 21.1 percent to AED562 million. Its EBITDA margin improved to 22.5 percent during the first half of the year.
Revenue from the Medical Centres segment increased by 8.4 percent to AED248 million, while adjusted EBITDA rose by 56.2 percent to AED28 million.
Operating cash flow grew by 76.8 percent to AED405 million, while free cash flow reached AED354 million. Free cash flow conversion stood at 72 percent.
Return on capital employed increased to 13.6 percent, compared with 12.4 percent during the corresponding period last year.
Burjeel Holdings maintained a stable net leverage ratio of 1.8 times as of June 30, 2026.
On July 1, the group completed the issuance of US$500 million in Sukuk under its US$1.5 billion Sukuk Programme. The proceeds were used to refinance existing debt.
Outstanding debt stood at AED1.915 billion as of July 31, while the group had AED672 million in committed and undrawn credit facilities available.
Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, said the group would continue investing in advanced clinical care, research, medical education, digital transformation and AI-enabled healthcare.
He added that these investments would help Burjeel capture future growth opportunities, deliver sustainable value and support the development of the next generation of healthcare services.
